Aida Hajjar Sesé1, Jens Lindegaard2, Hanne Olsen Julian3, Klavs Højgaard-Olsen4, Niels Frimodt Møller5, Steffen Heegaard4,6. 1. Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. aida.oftalmo@gmail.com. 2. Copenhagen Eye Infirmary, Copenhagen, Denmark. 3. Department of Ophthalmology, Mølholm Private Hospital, Vejle, Denmark. 4. Department of Ophthalmology, Rigshospitalet-Glostrup, University of Copenhagen, Glostrup, Denmark. 5. Department of Microbiology, Rigshospitalet, University of Copenhagen, Glostrup, Denmark. 6. Department of Pathology, Eye Pathology Section, Rigshospitalet, University of Copenhagen, Glostrup, Denmark.
Abstract
PURPOSE: Donor-to-host transmission of infectious agents is a rare but well-recognised complication of corneal transplantation and may carry a grave visual prognosis. In this case series, we describe the clinical features and risk factors of using culture-positive donor corneas for transplantation. METHODS: Retrospective chart review of a series of patients who underwent either penetrating keratoplasty (PK) or Descemet's stripping automated endothelial keratoplasty (DSAEK) with positive microbiology cultivation during routine assessment of donor corneal tissue obtained at the time of surgery. Donor and recipient characteristics, tissue preparation and surgical parameters, clinical signs and outcomes were registered. RESULTS: Eleven patients who received culture-positive corneal grafts were identified: six with Candida, three with Gram-positive bacteria and two with Gram-negative bacteria. Three patients developed clinical keratitis after routine DSAEK using corneas contaminated with Candida species. The median death-to-preservation time (DPT) of these three donor corneas was 18.08 (range 18.08 to 20.90) h, while in the remaining eight donors, it was 12.27 (range 9.32 to 20.47) h. Despite the initiation of antifungal treatment, all three cases required explantation of the graft and a subsequent re-DSAEK. CONCLUSIONS: The use of donor corneas that are culture-positive for Candida carries a risk for developing postoperative keratitis and the risk may be higher in DSAEK. Unlike the cold storage technique employed for donor corneas described in this case series, organ culture technique requires microbiological screening and supplementation of an antifungal agent which may reduce the risk of donor-to-host transmission of fungal infection.
PURPOSE:Donor-to-host transmission of infectious agents is a rare but well-recognised complication of corneal transplantation and may carry a grave visual prognosis. In this case series, we describe the clinical features and risk factors of using culture-positive donor corneas for transplantation. METHODS: Retrospective chart review of a series of patients who underwent either penetrating keratoplasty (PK) or Descemet's stripping automated endothelial keratoplasty (DSAEK) with positive microbiology cultivation during routine assessment of donor corneal tissue obtained at the time of surgery. Donor and recipient characteristics, tissue preparation and surgical parameters, clinical signs and outcomes were registered. RESULTS: Eleven patients who received culture-positive corneal grafts were identified: six with Candida, three with Gram-positive bacteria and two with Gram-negative bacteria. Three patients developed clinical keratitis after routine DSAEK using corneas contaminated with Candida species. The median death-to-preservation time (DPT) of these three donor corneas was 18.08 (range 18.08 to 20.90) h, while in the remaining eight donors, it was 12.27 (range 9.32 to 20.47) h. Despite the initiation of antifungal treatment, all three cases required explantation of the graft and a subsequent re-DSAEK. CONCLUSIONS: The use of donor corneas that are culture-positive for Candida carries a risk for developing postoperative keratitis and the risk may be higher in DSAEK. Unlike the cold storage technique employed for donor corneas described in this case series, organ culture technique requires microbiological screening and supplementation of an antifungal agent which may reduce the risk of donor-to-host transmission of fungal infection.
Authors: Anna S Kitzmann; Kenneth M Goins; Cynthia Reed; Lissa Padnick-Silver; Marian S Macsai; John E Sutphin Journal: Cornea Date: 2008-07 Impact factor: 2.651
Authors: Alan Sugar; Robin L Gal; roy W Beck; Katrina J Ruedy; Christopher L Blanton; Robert S Feder; David R Hardten; Edward J Holland; Jonathan H Lass; Mark J Mannis; Michael B O'Keefe Journal: Cornea Date: 2005-05 Impact factor: 2.651
Authors: David C Ritterband; Mahendra K Shah; Seth W Meskin; John A Seedor; Richard S Koplin; Wilma Perez; Renee Yang; Dan Ning Hu; Patricia Dahl Journal: Cornea Date: 2007-04 Impact factor: 2.651
Authors: Luigi Fontana; Alice Caristia; Alessandra Cornacchia; Giuseppe Russello; Antonio Moramarco Journal: Int Ophthalmol Date: 2020-09-17 Impact factor: 2.031